Mutated JAK2 signal transduction in human induced pluripotent stem cell (iPSC)-derived megakaryocytes
Janus kinase 2 (JAK2) gene mutations are the main drivers for polycythemia vera (PV) and essential thrombocythemia (ET). The mechanisms of single altered gene causing two different diseases are unclear. Additionally, novel treatments specifically targeting mutated JAK2 proteins are needed. In this s...
Main Authors: | Jaturawat Pawinwongchai, Panchalee Jangprasert, Nungruthai Nilsri, Nipan Israsena, Ponlapat Rojnuckarin |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-07-01
|
Series: | Platelets |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09537104.2021.1981850 |
Similar Items
-
Distinct effects of V617F and exon12-mutated JAK2 expressions on erythropoiesis in a human induced pluripotent stem cell (iPSC)-based model
by: Nungruthai Nilsri, et al.
Published: (2021-03-01) -
Regulation of platelet numbers and sizes by signaling pathways
by: Jaturawat Pawinwongchai, et al.
Published: (2021-11-01) -
Megakaryocyte contribution to bone marrow fibrosis: many arrows in the quiver
by: Alessandro Malara, et al.
Published: (2018-11-01) -
Shared and Distinctive Ultrastructural Abnormalities Expressed by Megakaryocytes in Bone Marrow and Spleen From Patients With Myelofibrosis
by: Maria Zingariello, et al.
Published: (2020-11-01) -
Transcription factor 3 is dysregulated in megakaryocytes in myelofibrosis
by: Ryan J Collinson, et al.
Published: (2024-12-01)